![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1391, 2003-01, pp. : 19-19
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Infliximab appears to be beneficial in paediatric Crohn's disease
Inpharma, Vol. 1, Iss. 1256, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Infliximab: additional benefits in Crohn's disease
Inpharma, Vol. 1, Iss. 1349, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Infliximab worth it for Crohn's disease in the UK
Inpharma, Vol. 1, Iss. 1515, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Infliximab: First report of Crohn's disease: case report
Reactions Weekly, Vol. 1, Iss. 1155, 2007-01 ,pp. :